Lau Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,430
Closed -$265K 100
2018
Q3
$265K Buy
+3,430
New +$259K 0.15% 81
2017
Q4
Sell
-34,000
Closed -$2.75M 78
2017
Q3
$2.75M Buy
34,000
+2,000
+6% +$153K 2.14% 13
2017
Q2
$2.27M Buy
32,000
+6,500
+25% +$433K 1.81% 16
2017
Q1
$1.73M Sell
25,500
-200
-0.8% -$14.1K 1.55% 17
2016
Q4
$1.84M Sell
25,700
-2,200
-8% -$164K 1.86% 15
2016
Q3
$2.21M Sell
27,900
-700
-2% -$56.9K 2.24% 12
2016
Q2
$2.39M Sell
28,600
-800
-3% -$71K 2.51% 11
2016
Q1
$2.7M Buy
29,400
+200
+0.7% +$18K 2.79% 10
2015
Q4
$2.96M Buy
29,200
+200
+0.7% +$20.8K 3.18% 9
2015
Q3
$2.85M Buy
29,000
+350
+1% +$38.9K 3.35% 8
2015
Q2
$3.35M Hold
28,650
3.29% 9
2015
Q1
$2.81M Buy
28,650
+2,650
+10% +$269K 2.68% 11
2014
Q4
$2.45M Buy
26,000
+300
+1% +$31K 2.23% 14
2014
Q3
$2.74M Buy
25,700
+6,600
+35% +$646K 2.52% 13
2014
Q2
$1.58M Buy
19,100
+3,400
+22% +$265K 1.43% 21
2014
Q1
$1.11M Buy
15,700
+200
+1% +$15.7K 0.99% 26
2013
Q4
$1.16M Sell
15,500
-4,500
-23% -$313K 1.03% 25
2013
Q3
$1.26M Hold
20,000
1.05% 22
2013
Q2
$1.02M Buy
+20,000
New +$1.04M 0.87% 27

Other funds holding GILD

Lau Associates's GILD Position: Q4 2018 in Review

Lau Associates sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,430 shares — an estimated $265K sold.

Lau Associates first reported a position in GILD in Q2 2013 and held it in 19 quarters. The position peaked at $3.35M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Lau Associates reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Lau Associates sold 3,430 Gilead Sciences shares in Q4 2018, an estimated $265K.
  • Lau Associates first reported a position in Gilead Sciences in Q2 2013 and held it in 19 quarters.
  • Lau Associates's Gilead Sciences position peaked at $3.35M in Q2 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Lau Associates's 13F filing for Q4 2018, filed 6 Feb 2019.